Carl Zeiss Meditec revenue and financials
In the fiscal year ended September 2025, Carl Zeiss Meditec reported revenue of €2.23B (+7.82% year over year). Net income was €141.21M, a net margin of 6.3%.
Fiscal year ending in September. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +7.82%
- FY to Sep 2025 vs FY to Sep 2024
- Net income growth
- −20.99%
- FY to Sep 2025 vs FY to Sep 2024
- Net margin
- 6.3%
- FY to Sep 2024: 8.7%
How Carl Zeiss Meditec is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 10.8% a year on average over the last 5 years
Compound annual growth rate: from €1.34B in 2020 to €2.23B in 2025.
Operating margin fell from 20.9% to 10.0%
Operating income over revenue, 2022 → 2025: 10.9 percentage points.
Free cash flow equal to 85% of net income
Totals for fiscal years 2023–2025: free cash flow €516.18M, net income €610.33M.
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | FY to Sep 2025 | FY to Sep 2024 | FY to Sep 2023 | FY to Sep 2022 | FY to Sep 2021 | FY to Sep 2020 | FY to Sep 2019 | FY to Sep 2018 | FY to Sep 2017 | FY to Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2,228 | 2,066 | 2,089 | 1,903 | 1,647 | 1,335 | 1,459 | 1,281 | 1,190 | 1,088 |
| Cost of revenue | 1,052 | 977 | 884 | 775 | 680 | 590 | 627 | 570 | 533 | 509 |
| Gross profit | 1,175 | 1,089 | 1,206 | 1,128 | 967 | 746 | 832 | 710 | 657 | 580 |
| Selling, general and administrative | 627 | 568 | 503 | 439 | 365 | 350 | 394 | 354 | 339 | 303 |
| Research and development | 326 | 343 | 349 | 291 | 232 | 219 | 173 | 160 | 146 | 123 |
| Operating income | 223 | 177 | 349 | 398 | 370 | 177 | 264 | 197 | 172 | 153 |
| EBIT | 223 | 177 | 349 | 398 | 370 | 177 | 264 | 197 | 172 | 153 |
| EBITDA | 274 | 215 | 371 | 418 | 389 | 200 | 284 | 218 | 191 | 169 |
| Interest expense | 26.6 | 29.4 | 15.3 | 9.1 | 8.6 | 27.3 | 7.7 | 2.1 | 1.7 | 2.2 |
| Pre-tax income | 194 | 241 | 413 | 403 | 339 | 179 | 230 | 179 | 189 | 142 |
| Income tax | 51.5 | 60.7 | 121 | 108 | 102 | 55.3 | 69.3 | 53.0 | 52.8 | 42.0 |
| Net income | 141 | 179 | 290 | 294 | 236 | 122 | 160 | 126 | 134 | 98.3 |
| Net income to common shareholders | 141 | 179 | 290 | 294 | 236 | 122 | 160 | 126 | 134 | 98.3 |
| Basic EPS | 1.61 | 2.01 | 3.25 | 3.29 | 2.64 | 1.37 | 1.79 | 1.41 | 1.57 | 1.21 |
| Diluted EPS | 1.61 | 2.01 | 3.25 | 3.29 | 2.64 | 1.37 | 1.79 | 1.41 | 1.57 | 1.21 |
| Average shares (basic) | 87.5 | 88.9 | 89.4 | 89.4 | 89.4 | 89.4 | 89.4 | 89.4 | 85.6 | 81.3 |
| Average shares (diluted) | 87.5 | 88.9 | 89.4 | 89.4 | 89.4 | 89.4 | 89.4 | 89.4 | 85.6 | 81.3 |
| Dividend per share | 0.55 | 0.60 | 1.10 | 1.10 | 0.90 | 0.50 | 0.65 | 0.55 | 0.55 | 0.42 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 563 | 524 | 467 | 628 | 550 | 560 | 491 | 580 | 539 | 472 | 475 | 580 |
| Cost of revenue | 260 | 261 | 240 | 296 | 260 | 258 | 238 | 289 | 246 | 220 | 223 | 239 |
| Gross profit | 302 | 263 | 227 | 332 | 290 | 302 | 252 | 290 | 293 | 253 | 253 | 340 |
| Selling, general and administrative | 162 | 151 | 152 | 170 | 154 | 154 | 149 | 173 | 155 | 119 | 121 | 139 |
| Research and development | 78.9 | 89.3 | 75.5 | 91.8 | 81.4 | 75.6 | 77.5 | 84.7 | 84.3 | 86.3 | 87.8 | 93.7 |
| Operating income | 62.3 | 25.5 | -0.3 | 70.4 | 53.7 | 71.2 | 28.0 | 13.8 | 54.7 | 65.0 | 43.8 | 103 |
| EBIT | 62.3 | 25.5 | -0.3 | 70.4 | 53.7 | 71.2 | 28.0 | 13.8 | 54.7 | 65.0 | 43.8 | 103 |
| EBITDA | 74.9 | 63.7 | 12.3 | 83.0 | 63.1 | 101 | 37.4 | 23.2 | 60.1 | 84.2 | 49.2 | 109 |
| Interest expense | 5.9 | 6.2 | 6.0 | 6.3 | 6.4 | 7.0 | 6.9 | 9.4 | 8.1 | 8.1 | 3.9 | 3.2 |
| Pre-tax income | 69.2 | 25.8 | -5.5 | 67.3 | 41.1 | 65.4 | 20.1 | 69.6 | 49.2 | 67.3 | 54.8 | 116 |
| Income tax | 16.4 | 6.8 | 0.2 | 13.0 | 13.5 | 19.8 | 5.2 | 6.6 | 15.9 | 20.2 | 18.0 | 30.4 |
| Net income | 55.0 | 19.6 | -4.9 | 51.8 | 28.4 | 45.3 | 15.7 | 60.7 | 34.1 | 46.5 | 37.4 | 85.2 |
| Net income to common shareholders | 55.0 | 19.6 | -4.9 | 51.8 | 28.4 | 45.3 | 15.7 | 60.7 | 34.1 | 46.5 | 37.4 | 85.2 |
| Basic EPS | 0.64 | 0.22 | -0.06 | 0.59 | 0.32 | 0.52 | 0.18 | 0.70 | 0.38 | 0.52 | 0.42 | 0.96 |
| Diluted EPS | 0.64 | 0.22 | -0.06 | 0.59 | 0.32 | 0.52 | 0.18 | 0.70 | 0.38 | 0.52 | 0.42 | 0.96 |
| Average shares (basic) | 86.3 | 89.0 | 81.7 | 87.2 | 87.9 | 87.2 | 87.2 | 87.2 | 89.4 | 89.4 | 89.0 | 88.9 |
| Average shares (diluted) | 86.3 | 89.0 | 81.7 | 87.2 | 87.9 | 87.2 | 87.2 | 87.2 | 89.4 | 89.4 | 89.0 | 88.9 |
| Dividend per share | — | — | — | 0.55 | — | — | — | 0.60 | — | — | — | 1.10 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | FY to Sep 2025 | FY to Sep 2024 | FY to Sep 2023 | FY to Sep 2022 | FY to Sep 2021 | FY to Sep 2020 | FY to Sep 2019 | FY to Sep 2018 | FY to Sep 2017 | FY to Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3,403 | 3,393 | 3,033 | 2,823 | 2,396 | 2,015 | 2,022 | 1,662 | 1,623 | 1,248 |
| Current assets | 1,280 | 1,212 | 1,912 | 1,792 | 1,604 | 1,294 | 1,304 | 1,251 | 1,208 | 859 |
| Cash and equivalents | 27.3 | 20.3 | 10.6 | 7.7 | 7.4 | 6.2 | 22.6 | 6.7 | 3.9 | 8.7 |
| Short-term investments | — | — | — | — | — | — | — | 1.2 | 4.4 | — |
| Receivables | 692 | 583 | 1,297 | 1,326 | 1,294 | 979 | 1,000 | 980 | 935 | 626 |
| Inventory | 497 | 537 | 520 | 383 | 286 | 286 | 268 | 248 | 234 | 208 |
| Net property, plant and equipment | 286 | 264 | 251 | 201 | 177 | 120 | 111 | 57.3 | 56.4 | 63.3 |
| Goodwill | 970 | 983 | 416 | 430 | 329 | 327 | 338 | 186 | 174 | 165 |
| Other intangible assets | 280 | 304 | 13.3 | 15.6 | 16.6 | 22.1 | 28.0 | 30.7 | 30.8 | 27.1 |
| Long-term investments | 28.9 | 20.4 | 21.5 | 10.8 | 6.7 | 4.1 | 5.2 | 0.1 | 19.3 | 0.1 |
| Current liabilities | 544 | 569 | 562 | 539 | 448 | 298 | 340 | 280 | 316 | 286 |
| Accounts payable | 194 | 184 | 240 | 189 | 145 | 91.7 | 118 | 101 | 100 | 86.5 |
| Long-term debt | 400 | 400 | — | — | — | — | — | — | — | — |
| Total debt | 535 | 554 | 156 | 128 | 121 | 68.6 | 57.5 | 10.9 | 5.8 | 9.0 |
| Total liabilities | 1,276 | 1,337 | 860 | 793 | 719 | 564 | 605 | 347 | 381 | 397 |
| Total equity (incl. minority) | 2,128 | 2,056 | 2,173 | 2,030 | 1,677 | 1,451 | 1,417 | 1,315 | 1,242 | 851 |
| Retained earnings | 1,575 | 1,486 | 1,406 | 1,214 | 1,000 | 809 | 745 | 632 | 555 | 458 |
| Minority interest | 11.2 | 14.8 | 13.5 | 15.0 | 18.1 | 18.8 | 18.5 | 21.2 | 26.4 | 53.3 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | 3,339 | — | 3,403 | — | 3,474 | — | 3,393 | — | 2,920 | — | 3,033 |
| Current assets | — | 1,233 | — | 1,280 | — | 1,284 | — | 1,212 | — | 1,779 | — | 1,912 |
| Cash and equivalents | — | 23.9 | — | 27.3 | — | 26.6 | — | 20.3 | — | 15.3 | — | 10.6 |
| Short-term investments | — | — | — | — | — | 24.9 | — | — | — | — | — | — |
| Receivables | — | 624 | — | 692 | — | 637 | — | 583 | — | 1,151 | — | 1,297 |
| Inventory | — | 539 | — | 497 | — | 551 | — | 537 | — | 555 | — | 520 |
| Net property, plant and equipment | — | 336 | — | 286 | — | 356 | — | 264 | — | 333 | — | 251 |
| Goodwill | — | 976 | — | 970 | — | 992 | — | 983 | — | 410 | — | 416 |
| Other intangible assets | — | 632 | — | 280 | — | 696 | — | 304 | — | 274 | — | 13.3 |
| Long-term investments | — | 36.2 | — | 28.9 | — | 22.4 | — | 20.4 | — | 14.0 | — | 21.5 |
| Current liabilities | — | 508 | — | 544 | — | 628 | — | 569 | — | 507 | — | 562 |
| Accounts payable | — | 186 | — | 194 | — | 189 | — | 184 | — | 187 | — | 240 |
| Long-term debt | — | 455 | — | 400 | — | 448 | — | 400 | — | — | — | — |
| Total debt | — | 581 | — | 535 | — | 595 | — | 554 | — | 142 | — | — |
| Total liabilities | — | 1,230 | — | 1,276 | — | 1,384 | — | 1,337 | — | 813 | — | 860 |
| Total equity (incl. minority) | 2,108 | 2,108 | 2,128 | 2,128 | — | 2,090 | 2,056 | 2,056 | — | 2,107 | 2,173 | 2,173 |
| Retained earnings | — | 1,542 | — | 1,575 | — | 1,495 | — | 1,486 | — | 1,392 | — | 1,406 |
| Minority interest | — | 9.4 | — | 11.2 | — | 14.1 | — | 14.8 | — | 13.1 | — | 13.5 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | FY to Sep 2025 | FY to Sep 2024 | FY to Sep 2023 | FY to Sep 2022 | FY to Sep 2021 | FY to Sep 2020 | FY to Sep 2019 | FY to Sep 2018 | FY to Sep 2017 | FY to Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 210 | 247 | 251 | 188 | 363 | 179 | 220 | 187 | 37.7 | 112 |
| Depreciation and amortization | 75.9 | 64.0 | 45.1 | 40.3 | 37.3 | 37.8 | 32.2 | 21.1 | 18.2 | 15.9 |
| Capital expenditure | -39.4 | -86.8 | -65.7 | -42.8 | -30.1 | -29.3 | -20.3 | -16.5 | -13.7 | -12.8 |
| Investing cash flow | -91.0 | -412 | -111 | -92.9 | -75.2 | -70.9 | -146 | -28.9 | -55.9 | 77.3 |
| Financing cash flow | -109 | 176 | -135 | -94.2 | -286 | -123 | -58.6 | -157 | 14.5 | -195 |
| Dividends paid | -52.5 | -98.2 | -98.4 | -80.5 | -44.7 | -58.1 | -49.2 | -49.2 | -37.6 | -30.9 |
| Share repurchases | 0.0 | -150 | 0.0 | — | — | — | — | — | — | — |
| Debt issued | 0.1 | 400 | 0.0 | — | 4.4 | 0.0 | — | — | 0.2 | — |
| Debt repaid | -23.4 | -23.3 | -23.0 | -22.0 | -17.7 | -16.1 | -13.8 | -3.5 | -3.3 | -3.2 |
| Effect of exchange rates | -3.0 | -1.6 | -1.9 | -0.8 | -0.3 | -1.1 | 0.8 | -0.3 | -1.1 | 1.6 |
| Net change in cash | 7.0 | 9.7 | 2.9 | 0.3 | 1.2 | -16.4 | 16.0 | 2.8 | -4.8 | -4.3 |
| Free cash flow | 170 | 161 | 185 | 145 | 333 | — | — | — | — | — |
| Levered free cash flow | 87.3 | 784 | 73.9 | 132 | 59.3 | 60.3 | 172 | 37.8 | -227 | -67.9 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q1 2026 | Q3 2025 | Q1 2025 | Q3 2024 | Q1 2024 |
|---|---|---|---|---|---|
| Operating cash flow | — | 144 | 34.8 | — | — |
| Investing cash flow | — | -98.9 | 2.1 | — | — |
| Financing cash flow | — | -50.8 | -36.2 | — | — |
| Free cash flow | — | 67.6 | -5.8 | — | — |
Financial statements of similar companies
Companies in the group: same industry, similar size
